Sign Up to like & get
recommendations!
0
Published in 2019 at "International Journal of Technology Assessment in Health Care"
DOI: 10.1017/s026646231900117x
Abstract: Introduction Most new oncology therapies are studied in the advanced/metastatic setting. However, there is an increasing focus on earlier stage disease. Nevertheless, measuring Overall Survival (OS) in neo-/adjuvant therapy trials can be very challenging due…
read more here.
Keywords:
technology assessment;
survival metrics;
neo adjuvant;
health ... See more keywords